Get to know our Pipeline
![](https://immpact-bio.com/wp-content/uploads/2024/05/Pipeline-UPDATED-5-20-24.png)
Learn More About our Technology
![](https://immpact-bio.com/wp-content/uploads/2023/04/Cells-no-stock-2.png)
Bispecific Chimeric Antigen Receptor (CAR) T cells are designed to address antigen escape
![](https://immpact-bio.com/wp-content/uploads/2023/04/Cells-no-stock-2.png)
TGF-β CAR rewires T cell responses to soluble factors to overcome the immune suppressive microenvironment in cancer
![](https://immpact-bio.com/wp-content/uploads/2023/04/Cells-no-stock-2.png)
Bispecific Chimeric Antigen Receptor (CAR) T cells are designed to address antigen escape
![](https://immpact-bio.com/wp-content/uploads/2023/04/Cells-no-stock-2.png)
Bispecific Chimeric Antigen Receptor (CAR) T cells are designed to address autoimmunity
![](https://immpact-bio.com/wp-content/uploads/2023/04/Cells-no-stock-2.png)
Bispecific Chimeric Antigen Receptor (CAR) T cells are designed to address autoimmunity
![](https://immpact-bio.com/wp-content/uploads/2023/04/Cells-no-stock-2.png)
iCAR technology allows specific killing of cancer cells while sparing normal tissue, with potential to treat all solid tumors
![](https://immpact-bio.com/wp-content/uploads/2023/04/Cells-no-stock-2.png)
TGF-β CAR rewires T cell responses to soluble factors to overcome the immune suppressive microenvironment in cancer.
![](https://immpact-bio.com/wp-content/uploads/2023/04/Cells-no-stock-2.png)
iCAR technology allows specific killing of cancer cells while sparing normal tissue, with potential to treat all solid tumors.